BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25183049)

  • 1. Expression and clinical significance of IMP3 in microdissected premalignant and malignant pancreatic lesions.
    Wang BJ; Wang L; Yang SY; Liu ZJ
    Clin Transl Oncol; 2015 Mar; 17(3):215-22. PubMed ID: 25183049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma.
    Zhang JJ; Zhu Y; Zhu Y; Wu JL; Liang WB; Zhu R; Xu ZK; Du Q; Miao Y
    Clin Transl Oncol; 2012 Feb; 14(2):116-24. PubMed ID: 22301400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
    Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
    Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of IMP3 and p53 expression in endoscopic ultrasound-guided fine needle aspiration and resected specimens of pancreatic diseases.
    Senoo J; Mikata R; Kishimoto T; Hayashi M; Kusakabe Y; Yasui S; Yamato M; Ohyama H; Sugiyama H; Tsuyuguchi T; Yoshitomi H; Ohtsuka M; Maeda J; Ota S; Nakatani Y; Kato N
    Pancreatology; 2018 Mar; 18(2):176-183. PubMed ID: 29305088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm.
    Morimatsu K; Aishima S; Yamamoto H; Hayashi A; Nakata K; Oda Y; Shindo K; Fujino M; Tanaka M; Oda Y
    Hum Pathol; 2013 Sep; 44(9):1714-21. PubMed ID: 23597774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of long non-coding RNA LOC285194 and its prognostic significance in human pancreatic ductal adenocarcinoma.
    Ding YC; Yu W; Ma C; Wang Q; Huang CS; Huang T
    Int J Clin Exp Pathol; 2014; 7(11):8065-70. PubMed ID: 25550852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma.
    Zhu Y; Zhang JJ; Zhu R; Zhu Y; Liang WB; Gao WT; Yu JB; Xu ZK; Miao Y
    Med Oncol; 2011 Dec; 28 Suppl 1():S175-84. PubMed ID: 20922503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of insulin-like growth factor 2 binding protein 3 (IMP3) in pancreatic cancer cell migration, invasion, and adhesion.
    Pasiliao CC; Chang CW; Sutherland BW; Valdez SM; Schaeffer D; Yapp DT; Ng SS
    BMC Cancer; 2015 Apr; 15():266. PubMed ID: 25886367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer.
    Lukosiute-Urboniene A; Jasukaitiene A; Silkuniene G; Barauskas V; Gulbinas A; Dambrauskas Z
    World J Gastroenterol; 2019 Jan; 25(2):205-219. PubMed ID: 30670910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays.
    Grützmann R; Pilarsky C; Ammerpohl O; Lüttges J; Böhme A; Sipos B; Foerder M; Alldinger I; Jahnke B; Schackert HK; Kalthoff H; Kremer B; Klöppel G; Saeger HD
    Neoplasia; 2004; 6(5):611-22. PubMed ID: 15548371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Koga A; Sato N; Kohi S; Yabuki K; Cheng XB; Hisaoka M; Hirata K
    Pancreatology; 2017; 17(1):115-122. PubMed ID: 28012880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNAs expressed in pancreatic ductal adenocarcinoma and lncRNA BC008363 an independent prognostic factor in PDAC.
    Li J; Liu D; Hua R; Zhang J; Liu W; Huo Y; Cheng Y; Hong J; Sun Y
    Pancreatology; 2014; 14(5):385-90. PubMed ID: 25200694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma.
    Huang Y; Ren GP; Xu C; Dong SF; Wang Y; Gan Y; Zhu L; Feng TY
    BMC Cancer; 2014 Jul; 14():479. PubMed ID: 24989027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor 2 binding protein 3 expression on endoscopic ultrasound guided fine needle aspiration specimens in pancreatic ductal adenocarcinoma.
    Tadic M; Stoos-Veic T; Kujundzic M; Turcic P; Aralica G; Boskoski I
    Eur J Gastroenterol Hepatol; 2020 Apr; 32(4):496-500. PubMed ID: 32109929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
    Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
    World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of AGR2 in pancreatic ductal adenocarcinoma.
    Riener MO; Pilarsky C; Gerhardt J; Grützmann R; Fritzsche FR; Bahra M; Weichert W; Kristiansen G
    Histol Histopathol; 2009 Sep; 24(9):1121-8. PubMed ID: 19609859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated transcript levels from the MDM2 P1 promoter and low p53 transcript levels are associated with poor prognosis in human pancreatic ductal adenocarcinoma.
    Grochola LF; Taubert H; Greither T; Bhanot U; Udelnow A; Würl P
    Pancreas; 2011 Mar; 40(2):265-70. PubMed ID: 21404460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of microRNA-141 expression and its tumor suppressor function in human pancreatic ductal adenocarcinoma.
    Zhu ZM; Xu YF; Su QJ; Du JD; Tan XL; Tu YL; Tan JW; Jiao HB
    Mol Cell Biochem; 2014 Mar; 388(1-2):39-49. PubMed ID: 24242138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.